SUCCESSFUL TREATMENT AND PROPHYLAXIS OF SCALP SEBORRHEIC DERMATITIS AND DANDRUFF WITH 2-PERCENT KETOCONAZOLE SHAMPOO - RESULTS OF A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引:68
|
作者
PETER, RU [1 ]
RICHARZBARTHAUER, U [1 ]
机构
[1] JANSSEN RES FDN,W-4040 NEUSS,GERMANY
关键词
D O I
10.1111/j.1365-2133.1995.tb08680.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pityrosporum ovale appears to play an important role in the pathogenesis of seborrhoeic dermatitis. Ketoconazole is an antimycotic agent with a high in vitro and in vivo efficacy against P. ovale. We performed a multicentre study to investigate the efficacy of ketoconazole 2% shampoo in the treatment and prophylaxis of seborrhoeic dermatitis and dandruff. Five hundred and seventy-five patients presenting with moderate to severe seborrhoeic dermatitis and dandruff of the scalp were treated with 2% ketoconazole shampoo twice weekly for 2-4 weeks, producing an excellent response in 88%. Of those patients who responded, 312 were included in a prophylactic phase, lasting 6 months. These patients were treated with the active preparation (shampoo containing 2% ketoconazole) once-weekly, once every other week, alternating with placebo (shampoo without ketoconazole), or with placebo only once-weekly. Forty-eight (47%) patients in the placebo group experienced a relapse of seborrhoeic dermatitis compared with 23 (19%) patients in the active treatment group, and 31 (31%) patients in the active/placebo group. The medication was well tolerated in all three groups. We conclude that ketoconazole 2% shampoo is highly effective, not only in clearing scalp seborrhoeic dermatitis and dandruff, but also in preventing relapse of the disease when used prophylactically once weekly.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 50 条
  • [31] Milnacipran for the treatment of fibromyalgia syndrome: a european multicenter, double-blind, placebo-controlled trial
    Branco, J.
    Bragee, G.
    Zachrisson, O.
    Mikkelsen, K.
    De Teresa, L.
    Mainguy, Y.
    Galissie, M.
    Lugardon, S.
    Pezous, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S574 - S575
  • [32] INTRAVENOUS NICARDIPINE FOR THE TREATMENT OF SEVERE HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL
    WALLIN, JD
    FLETCHER, E
    RAM, CVS
    COOK, ME
    CHEUNG, DG
    MACCARTHY, EP
    TOWNSEND, R
    SAUNDERS, E
    DAVIS, WR
    LANGFORD, HG
    DEVAULT, G
    FLAMENBAUM, W
    ELLRODT, G
    HAMILTON, B
    FRANK, S
    FRISHMAN, W
    ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (12) : 2662 - 2669
  • [33] Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
    Levin, B
    Thompson, JLP
    Levy, G
    Mitsumoto, H
    Kaufmann, P
    NEUROLOGY, 2006, 66 (11) : 1786 - 1786
  • [34] Cabergoline in advanced RLS: A double-blind, placebo-controlled, multicenter trial
    Stiasny-Kolster, K
    Ueberall, M
    Oertel, W
    MOVEMENT DISORDERS, 2002, 17 : S231 - S231
  • [35] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
    Meininger, V
    Asselain, B
    Guillet, P
    Leigh, PN
    Ludolph, A
    Lacomblez, L
    Robberecht, W
    NEUROLOGY, 2006, 66 (01) : 88 - 92
  • [36] A multicenter, double-blind, placebo-controlled trial of topiramate in essential tremor
    Jankovic, J
    Ondo, WG
    Stacy, MA
    Elble, RJ
    Pahwa, R
    Connor, GS
    Hulihan, JF
    Schwarzman, L
    Wu, SC
    MOVEMENT DISORDERS, 2004, 19 : S448 - S449
  • [37] Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp
    Buechner, Stanislaw A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (03) : 226 - 231
  • [38] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Xu, Jane
    Phillips, Debra
    Simonelli, Doreen
    Kalali, Amir
    Loebel, Antony
    Meltzer, Herbert
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 493 - 493
  • [39] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL
    Meltzer, Herbert Y.
    Cucchiaro, Josephine
    Silva, R.
    Ogasa, M.
    Phillips, D.
    Xu, J.
    Kalali, A. H.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 315 - 315
  • [40] Efficacy and safety of avanafil for the treatment of erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled trial
    Park, J. K.
    Zhao, C.
    Kim, S. W.
    Yang, D. Y.
    Kim, J. J.
    Park, N. C.
    Lee, S. W.
    Paick, J. S.
    Ahn, T. Y.
    Moon, K. H.
    Chung, W. S.
    Min, K. S.
    Suh, J. K.
    Hyun, J. S.
    Park, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E701 - U494